|
1
|
Qiao F, Atkinson C, Song H, Pannu R, Singh
I and Tomlinson S: Complement plays an important role in spinal
cord injury and represents a therapeutic target for improving
recovery following trauma. Am J Pathol. 169:1039–1047. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karimi-Abdolrezaee S, Eftekharpour E, Wang
J, Morshead CM and Fehlings MG: Delayed transplantation of adult
neural precursor cells promotes remyelination and functional
neurological recovery after spinal cord injury. J Neurosci.
26:3377–3389. 2006. View Article : Google Scholar
|
|
3
|
Fawcett J: Repair of spinal cord injuries:
where are we, where are we going? Spinal Cord. 40:615–623. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nandoe Tewarie RS, Hurtado A, Bartels RH,
Grotenhuis A and Oudega M: Stem cell-based therapies for spinal
cord injury. J Spinal Cord Med. 32:105–114. 2009.
|
|
5
|
Lankford KL, Imaizumi T, Honmou O and
Kocsis JD: A quantitative morphometric analysis of rat spinal cord
remyelination following transplantation of allogenic Schwann cells.
J Comp Neurol. 443:259–274. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schaal SM, Kitay BM, Cho KS, Lo TP Jr,
Barakat DJ, Marcillo AE, Sanchez AR, Andrade CM and Pearse DD:
Schwann cell transplantation improves reticulospinal axon growth
and forelimb strength after severe cervical spinal cord contusion.
Cell Transplant. 16:207–208. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Golden KL, Pearse DD, Blits B, Garg MS,
Oudega M, Wood PM and Bunge MB: Transduced Schwann cells promote
axon growth and myelination after spinal cord injury. Exp Neurol.
207:203–217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lavdas AA, Franceschini I, Dubois-Dalcq M
and Matsas R: Schwann cells genetically engineered to express PSA
show enhanced migratory potential without impairment of their
myelinating ability in vitro. Glia. 53:868–878. 2006. View Article : Google Scholar
|
|
9
|
Bunge MB: Bridging the transected or
contused adult rat spinal cord with Schwann cell and olfactory
ensheathing glia transplants. Prog Brain Res. 137:275–282. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lavdas AA, Papastefanaki F, Thomaidou D
and Matsas R: Schwann cell transplantation for CNS repair. Curr Med
Chem. 15:151–160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Levi AD, Bunge RP, Lofgren JA, Meima L,
Hefti F, Nikolics K and Sliwkowski MX: The influence of heregulins
on human Schwann cell proliferation. J Neurosci. 15:1329–1340.
1995.PubMed/NCBI
|
|
12
|
Lin LF, Doherty DH, Lile JD, Bektesh S and
Collins F: GDNF: a glial cell line-derived neurotrophic factor for
midbrain dopaminergic neurons. Science. 260:1130–1132. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nandoe Tewarie RS, Hurtado A, Bartels RH,
Grotenhuis A and Oudega M: Stem cell-based therapies for spinal
cord injury. J Spinal Cord Med. 32:105–114. 2009.
|
|
14
|
Henderson CE, Phillips HS, Pollock RA,
Davies AM, Lemeulle C, Armanini M, Simpson LC, Moffet B, Vandlen
RA, Koliatsos VE and Rosenthal A: GDNF: a potent survival factor
for motoneurons present in peripheral nerve and muscle. Science.
266:1062–1064. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tomac A, Lindqvist E, Lin LF, Ögren SO,
Young D, Hoffer BJ and Olson L: Protection and repair of the
nigrostriatal dopaminergic system by GDNF in vivo. Nature.
373:335–339. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan Q, Matheson C and Lopez OT: In vivo
neurotrophic effects of GDNF on neonatal and adult facial motor
neurons. Nature. 373:341–344. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Beck KD, Valverde J, Alexi T, Poulsen K,
Moffat B, Vandlen RA, Rosenthal A and Hefti F: Mesencephalic
dopaminergic neurons protected by GDNF from axotomy-induced
degeneration in the adult brain. Nature. 373:339–341. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ansorena E, Garbayo E, Lanciego JL,
Aymerich MS and Blanco-Prieto MJ: Production of highly pure human
glycosylated GDNF in a mammalian cell line. Int J Pharm. 385:6–11.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng H, Wu JP and Tzeng SF:
Neuroprotection of glial cell line-derived neurotrophic factor in
damaged spinal cords following contusive injury. J Neurosci Res.
69:397–405. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sharma HS: Post-traumatic application of
brain-derived neurotrophic factor and glia-derived neurotrophic
factor on the rat spinal cord enhances neuroprotection and improves
motor function. Acta Neurochir Suppl. 96:329–334. 2006. View Article : Google Scholar
|
|
21
|
Guzen FP, De Almeida Leme RJ, de Andrade
MS, de Luca BA and Chadi G: Glial cell line-derived neurotrophic
factor added to a sciatic nerve fragment grafted in a spinal cord
gap ameliorates motor impairments in rats and increases local
axonal growth. Restor Neurol Neurosci. 27:1–16. 2009.
|
|
22
|
Zhang L, Ma Z, Smith GM, Wen X, Pressman
Y, Wood PM and Xu XM: GDNF-enhanced axonal regeneration and
myelination following spinal cord injury is mediated by primary
effects on neurons. Glia. 57:1178–1191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Piquilloud G, Christen T, Pfister LA,
Gander B and Papaloizos MY: Variations in glial cell line-derived
neurotrophic factor release from biodegradable nerve conduits
modify the rate of functional motor recovery after rat primary
nerve repairs. Eur J Neurosci. 26:1109–1117. 2007. View Article : Google Scholar
|
|
24
|
Lang AE, Gill S, Patel NK, Lozano A, Nutt
JG, Penn R, Brooks DJ, Hotton G, Moro E, Heywood P, Brodsky MA,
Burchiel K, Kelly P, Dalvi A, Scott B, Stacy M, Turner D, Wooten
VG, Elias WJ, Laws ER, Dhawan V, Stoessl AJ, Matcham J, Coffey RJ
and Traub M: Randomized controlled trial of intraputamenal glial
cell line-derived neurotrophic factor infusion in Parkinson
disease. Ann Neuro. 59:459–466. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Carnicella S and Ron D: GDNF, a potential
target to treat addiction. Pharmacol Ther. 122:9–18. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moreels M, Vandenabeele F, Deryck L and
Lambrichts I: Radial glial cells derived from the neonatal rat
spinal cord: morphological and immunocytochemical characterization.
Arch Hictol Cytol. 68:361–369. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun X, Liu M, Wei Y, Liu F, Zhi X, Xu R
and Krissansen GW: Overexpression of von Hippel-Lindau tumor
suppressor protein and antisense HIF-1alpha eradicates gliomas.
Cancer Gene Ther. 13:428–435. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bampton ET and Taylor JS: Effects of
Schwann cell secreted factors on PC12 cell neuritogenesis and
survival. J Neurobiol. 63:29–48. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Afshari FT, Kwok JC, White L and Fawcett
JW: Schwann cell migration is integrin-dependent and inhibited by
astrocyte-produced aggrecan. Glia. 58:857–869. 2010.PubMed/NCBI
|
|
30
|
Pearse DD, Sanchez AR, Pereira FC, Andrade
CM, Puzis R, Pressman Y, Golden K, Kitay BM, Blits B, Wood PM and
Bunge MB: Transplantation of Schwann cells and/or olfactory
ensheathing glia into the contused spinal cord: Survival,
migration, axon association, and functional recovery. Glia.
55:976–1000. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Takami T, Oudega M, Bates ML, Wood PM,
Kleitman N and Bunge MB: Schwann cell but not olfactory ensheathing
glia transplants improve hindlimb locomotor performance in the
moderately contused adult rat thoracic spinal cord. J Neurosci.
22:6670–6681. 2002.PubMed/NCBI
|
|
32
|
Saberi H, Moshayedi P, Aghayan HR, Arjmand
B, Hosseini SK, Emami-Razavi SH, Rahimi-Movaghar V, Raza M and
Firouzi M: Treatment of chronic thoracic spinal cord injury
patients with autologous Schwann cell transplantation: an interim
report on safety considerations and possible outcomes. Neurosci
Lett. 443:46–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zabner J, Ramsey BW, Meeker DP, et al:
Repeat administration of an adenovirus vector encoding cystic
fibrosis transmembrane conductance regulator to the nasal
epithelium of patients with cystic fibrosis. J Clin Invest.
97:1504–1511. 1996. View Article : Google Scholar
|
|
34
|
Giehl KM, Schacht CM, Yan Q and Mestres P:
GDNF is a trophic factor for adult rat corticospinal neurons and
promotes their long-term survival after axotomy in vivo. Eur J
Neurosci. 9:2479–2488. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cheng H, Wu JP and Tzeng SF:
Neuroprotection of glial cell line-derived neurotrophic factor in
damaged spinal cords following contusive injury. J Neurosci Res.
69:397–405. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guzen FP, de Almeida Leme RJ, de Andrade
MS, de Luca BA and Chadi G: Glial cell line-derived neurotrophic
factor added to a sciatic nerve fragment grafted in a spinal cord
gap ameliorates motor impairments in rats and increases local
axonal growth. Restor Neurol Neurosci. 27:1–16. 2009.PubMed/NCBI
|
|
37
|
Gerngross TU: Advances in the production
of human therapeutic proteins in yeasts and filamentous fungi. Nat
Biotechnol. 22:1409–1414. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takada N, Isogai E, Kawamoto T, Nakanishi
H, Todo S and Nakagawara A: Retinoic acid-induced apoptosis of the
CHP134 neuroblastoma cell line is associated with nuclear
accumulation of p53 and is rescued by the GDNF/Ret signal. Med
Pediatr Oncol. 36:122–126. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
McAlhany RE Jr, West JR and Miranda RC:
Glial-derived neurotrophic factor (GDNF) prevents ethanol-induced
apoptosis and JUN kinase phosphorylation. Brain Res Dev Brain Res.
119:209–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Villegas SN, Njaine B, Linden R and Carri
NG: Glial-derived neurotrophic factor (GDNF) prevents ethanol
(EtOH) induced B92 glial cell death by both PI3K/AKT and MEK/ERK
signaling pathways. Brain Res Bull. 71:116–126. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ghribi O, Herman MM, Forbes MS, DeWitt DA
and Savory J: GDNF protects against aluminum-induced apoptosis in
rabbits by upregulating Bcl-2 and Bcl-XL and inhibiting
mitochondrial Bax translocation. Neurobiol Dis. 8:764–773. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Walensky LD: BCL-2 in the crosshairs:
tipping the balance of life and death. Cell Death Differ.
13:1339–1350. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado
AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by
Bcl-2: release of cytochrome c from mitochondria blocked. Science.
275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
